Pain Project ACD440 Granted Orphan Drug Status in the EU
STOCKHOLM, SE / ACCESS Newswire / February 24, 2026 / AlzeCure Pharma AB (publ) (FN STO:ALZCUR)(STO:ALZCUR)(FRA:AC6), a biotech company that
STOCKHOLM, SE / ACCESS Newswire / February 24, 2026 / AlzeCure Pharma AB (publ) (FN STO:ALZCUR)(STO:ALZCUR)(FRA:AC6), a biotech company that
TORONTO, ON / ACCESS Newswire / February 24, 2026 / Galway Metals Inc. (TSX-V:GWM)(OTCQB:GAYMF) (the “Company” or “Galway”) is pleased
LAFAYETTE, LA / ACCESS Newswire / February 24, 2026 / Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national
STOCKHOLM, SE / ACCESS Newswire / February 24, 2026 / Compliance teams are moving faster with generative AI, but some
STOCKHOLM, SE / ACCESS Newswire / February 24, 2026 / Compliance teams are moving faster with generative AI, but some
STOCKHOLM, SE / ACCESS Newswire / February 24, 2026 / Compliance teams are moving faster with generative AI, but some
LOS ANGELES, CA / ACCESS Newswire / February 24, 2026 / Kingbull today announced the launch of its latest retro-style
LOS ANGELES, CA / ACCESS Newswire / February 24, 2026 / Kingbull today announced the launch of its latest retro-style
LOS ANGELES, CA / ACCESS Newswire / February 24, 2026 / Kingbull today announced the launch of its latest retro-style
TORONTO, ON / ACCESS Newswire / February 24, 2026 / Psyence Group Inc. (CSE:PSYG) (“Psyence” or the “Company”) announces that
RANCHO CUCAMONGA, CA / ACCESS Newswire / February 24, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food
TORONTO, ON / ACCESS Newswire / February 24, 2026 / Psyence Group Inc. (CSE:PSYG) (“Psyence” or the “Company”) announces that
Copyright © 2026 Emirates News Online. All Right Reserved.